Mutational Signature Analysis Reveals Widespread Contribution of Pyrrolizidine Alkaloid Exposure to Human Liver Cancer. He Y, Shi M, Wu X, Ma J, et al. Hepatology 2021;74:264-280.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

He Y, Shi M, Wu X, Ma J, et al. Mutational Signature Analysis Reveals Widespread Contribution of Pyrrolizidine Alkaloid Exposure to Human Liver Cancer. Hepatology 2021;74:264-280.
PMID: 33462832